MeSH tree: D12.776.260
B-ALL is the most common pediatric cancer and, over the years and thanks to a very effective treatment based on glucocorticoids, its 5-year survival rates have reached 85% and beyond. However, there is a B-ALL subtype, commonly ...
Aug 5, 2024
0
40
University of Queensland researchers have unlocked crucial molecular secrets of aging in cells, potentially paving the way to improve quality of life as people age.
Jul 8, 2024
0
72
Monocytes, a special type of white blood cell, secrete cytokines as inflammatory messengers that are crucial for an appropriate immune response. Researchers at the University Hospital Bonn (UKB) and the University of Bonn ...
Jul 8, 2024
0
31
Many vaccines are only partially effective, have waning efficacy, or do not work well in the very young or the very old. For more than a decade, Ofer Levy, MD, Ph.D., and David Dowling, Ph.D., in the Precision Vaccines Program ...
Jul 3, 2024
0
62
Recently, a research team led by Prof. Huang Qing at Hefei Institutes of Physical Science of Chinese Academy of Sciences found a new mechanism by which astaxanthin (AST) can target IL-6 and thus reduce LPS-induced adverse ...
May 30, 2024
0
53
A new paper by Dana-Farber Cancer Institute scientists lays the foundation for targeted therapies to inhibit the activation of nuclear factor kappa B (NF-κB), a transcription factor that plays a role in various autoimmune ...
Apr 25, 2024
0
33
Researchers from the UCLA Health Jonsson Comprehensive Cancer Center have shown for the first time that a gene usually linked to giant axonal neuropathy, a rare and severe neurological condition, also plays a role in inhibiting ...
Feb 29, 2024
0
44
Our immune system is remarkably powerful. It quickly assembles teams of cells to eliminate threats inside our bodies. But sometimes, it hits the wrong target. Autoimmune diseases like lupus and multiple sclerosis result from ...
Feb 20, 2024
0
38
If the oxygen level in organs and tissues falls below normal, hypoxia occurs. Then the body launches defensive responses. In many ways, they coincide and overlap with the response to inflammation, because this process is ...
Jan 16, 2024
0
26
For patients with early-stage breast cancer, there is a 7% to 11% chance of relapse within five years after receiving initial treatment, and this rate can be higher for patients with more advanced stages of the cancer. While ...
Dec 29, 2023
0
142
